Re: Question on valuing shares from time of spinoff

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Question on valuing shares from time of spinoff

in response to

Question on valuing shares from time of spinoff

bfw

posted on Sep 13, 2018 12:01AM

bfw - If memory serves correct ZEL was said to be about 9% of RVX. Personally I gave it a zero value at the time(as it is pretty much unimportant in Canada) and I am carrying it with a zero cost base. So in my case 100% of any sale price would be a capital gain. This is only important for non registered accounts in Canada.